Showing results (1551-1560 of 1,857) with videos related to
Sort By:
Pageof 186
The Lancet. Oncology|November 13, 2018
Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohortTodd M Gibson, Sogol Mostoufi-Moab, Kayla L Stratton, et al.Pediatrics|April 1, 1997
The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patientsK M Gibson, E Christensen, C Jakobs, et al.Radiation Research|December 4, 2019
Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor StudySara J Schonfeld, Rebecca M Howell, Susan A Smith, et al.Nature Communications|May 28, 2020
The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directionsThomas J Littlejohns, Jo Holliday, Lorna M Gibson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2020
Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood CancerMatthew J Ehrhardt, Zachary J Ward, Qi Liu, et al.JAMA Pediatrics|October 29, 2019
Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor StudyLene H Veiga, Rochelle E Curtis, Lindsay M Morton, et al.Journal of the National Cancer Institute|March 9, 2024
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor StudyDanielle Novetsky Friedman, Pamela J Goodman, Wendy M Leisenring, et al.CA: a Cancer Journal for Clinicians|January 30, 2018
Factors influencing risk-based care of the childhood cancer survivor in the 21st centuryStephanie B Dixon, Kari L Bjornard, Nicole M Alberts, et al.Kidney International|December 26, 2025
Nephrotic syndrome genomic discovery in the Mass General Brigham Biobank identifies monoallelic MEFV variants as a risk factor for focal segmental glomerulosclerosisJanewit Wongboonsin, Kristen M Gibson, Juntao Ke, et al.BMJ (Clinical Research Ed.)|June 17, 2021
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trialsMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.Pageof 186